The O-glycan epitope targeting anti-human carcinoma monoclonal antibody (mAb) NEO-201 can also target human regulatory T cells (Tregs)

被引：0
|
作者：
Tanaka, Atsushi
Fantini, Massimo
Arlen, Philip M.
Annunziata, Christina M.
Tsang, Kwong Y.
Sakaguchi, Shimon
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2716
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2716
引用
收藏
页数：2
相关论文
共 11 条
  • [1] IDENTIFICATION OF THE O-GLYCAN EPITOPE TARGETED BY AN ANTI-HUMAN CARCINOMA MONOCLONAL ANTIBODY (MAB) NEO-201
    Fantini, Massimo
    Zaki, Anjum
    Mavroukakis, Sharon
    Annunziata, Christina
    Arlen, Philip
    Tsang, Kwong
    Tsang, Kwong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A60 - A60
  • [2] Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201
    Tsang, Kwong Y.
    Fantini, Massimo
    Zaki, Anjum
    Mavroukakis, Sharon A.
    Morelli, Maria Pia
    Annunziata, Christina M.
    Arlen, Philip M.
    CANCERS, 2022, 14 (20)
  • [3] An anti-carcinoma monoclonal antibody (mAb) NEO-201 can also target and eliminate human immunosuppressive regulatory T cells (Tregs)
    Tsang, Kwong
    Fantini, Massimo
    David, Justin
    Morelli, M. Maria
    Annunzata, Christina
    Arlen, Philip
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [4] A therapeutic humanized anti-carcinoma monoclonal antibody (mAb) NEO-201 can also target human granulocytic myeloid-derived suppressor cells (gMDSCs) and regulatory T (Tregs) cells
    Fantini, Massimo
    Annunziata, Christina M.
    Arlen, Philip M.
    Tsang, Kwong Y.
    CANCER RESEARCH, 2023, 83 (07)
  • [5] AN ANTI-CARCINOMA MONOCLONAL ANTIBODY (MAB) NEO-201 CAN ALSO TARGET HUMAN ACUTE MYELOID LEUKEMIA (AML) CELL LINES IN VITRO
    Romano, Alessandra
    Parrinello, Nunziatina
    Marino, Sara
    La Spina, Enrico
    Fantini, Massimo
    Arlen, Philip
    Tsang, Kwong
    Di Raimondo, Francesco
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A925 - A925
  • [6] A THERAPEUTIC HUMANIZED ANTI-CARCINOMA MONOCLONAL ANTIBODY (MAB) CAN ALSO IDENTIFY IMMUNOSUPPRESSIVE REGULATORY T (TREGS) CELLS AND DOWN REGULATE TREG-MEDIATED IMMUNOSUPPRESSION
    Tsang, Kwong
    Fantini, Massimo
    Cole, Christopher
    Annunziata, Christina
    Arlen, Philip
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A881 - A881
  • [7] A therapeutic humanized anti-carcinoma monoclonal antibody (mAb) can enhance NK activity and target immunosuppressive regulatory T cells
    Fantini, Massimo
    Morelli, Maria Pia
    Annunziata, Christina M.
    Arlen, Philip M.
    Tsang, Kwong Y.
    CANCER RESEARCH, 2020, 80 (16)
  • [8] First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors
    Christopher B. Cole
    Maria Pia Morelli
    Massimo Fantini
    Markku Miettinen
    Patricia Fetsch
    Cody Peer
    William D. Figg
    Tyler Yin
    Nicole Houston
    Ann McCoy
    Stanley Lipkowitz
    Alexandra Zimmer
    Jung-min Lee
    Miroslava Pavelova
    Erin N. Villanueva
    Kathryn Trewhitt
    B. Brooke Solarz
    Maria Fergusson
    Sharon A. Mavroukakis
    Anjum Zaki
    Kwong Y. Tsang
    Philip M. Arlen
    Christina M. Annunziata
    Journal of Experimental & Clinical Cancer Research, 42
  • [9] First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors
    Cole, Christopher B.
    Morelli, Maria Pia
    Fantini, Massimo
    Miettinen, Markku
    Fetsch, Patricia
    Peer, Cody
    Figg, William D.
    Yin, Tyler
    Houston, Nicole
    McCoy, Ann
    Lipkowitz, Stanley
    Zimmer, Alexandra
    Lee, Jung-min
    Pavelova, Miroslava
    Villanueva, Erin N.
    Trewhitt, Kathryn
    Solarz, B. Brooke
    Fergusson, Maria
    Mavroukakis, Sharon A.
    Zaki, Anjum
    Tsang, Kwong Y.
    Arlen, Philip M.
    Annunziata, Christina M.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [10] An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells
    Fantini, Massimo
    David, Justin M.
    Wong, Hing C.
    Annunziata, Christina M.
    Arlen, Philip M.
    Tsang, Kwong Y.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (03) : 147 - 159
12